Correlation Between Santen Pharmaceutical and Horizon Pharma
Can any of the company-specific risk be diversified away by investing in both Santen Pharmaceutical and Horizon Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Santen Pharmaceutical and Horizon Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Santen Pharmaceutical Co and Horizon Pharma PLC, you can compare the effects of market volatilities on Santen Pharmaceutical and Horizon Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Santen Pharmaceutical with a short position of Horizon Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Santen Pharmaceutical and Horizon Pharma.
Diversification Opportunities for Santen Pharmaceutical and Horizon Pharma
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Santen and Horizon is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Santen Pharmaceutical Co and Horizon Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Horizon Pharma PLC and Santen Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Santen Pharmaceutical Co are associated (or correlated) with Horizon Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Horizon Pharma PLC has no effect on the direction of Santen Pharmaceutical i.e., Santen Pharmaceutical and Horizon Pharma go up and down completely randomly.
Pair Corralation between Santen Pharmaceutical and Horizon Pharma
If you would invest 10,040 in Horizon Pharma PLC on August 27, 2024 and sell it today you would earn a total of 0.00 from holding Horizon Pharma PLC or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Santen Pharmaceutical Co vs. Horizon Pharma PLC
Performance |
Timeline |
Santen Pharmaceutical |
Horizon Pharma PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Santen Pharmaceutical and Horizon Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Santen Pharmaceutical and Horizon Pharma
The main advantage of trading using opposite Santen Pharmaceutical and Horizon Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Santen Pharmaceutical position performs unexpectedly, Horizon Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Horizon Pharma will offset losses from the drop in Horizon Pharma's long position.Santen Pharmaceutical vs. Ono Pharmaceutical Co | Santen Pharmaceutical vs. GSK plc | Santen Pharmaceutical vs. Grifols SA ADR | Santen Pharmaceutical vs. Pfizer Inc |
Horizon Pharma vs. Bristol Myers Squibb | Horizon Pharma vs. AbbVie Inc | Horizon Pharma vs. Merck Company | Horizon Pharma vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |